article thumbnail

STAT+: AI drug firm Recursion moves from survival to industry domination

STAT

SALT LAKE CITY — On paper, Recursion Pharmaceuticals shouldn’t have worked.   The founders were a medical school dropout, an entrepreneur whose most recent success was with a custom sign-making e-commerce shop, and an exacting University of Utah scientist.

article thumbnail

STAT+: Endo Health ordered to pay more than $1.5 billion in opioid criminal case

STAT

In the second-largest fine ever levied on a pharmaceutical company, Endo Health Solutions was ordered to pay nearly $1.1 billion in criminal penalties and another $450 million in criminal forfeiture for illegally marketing its Opana ER prescription opioid.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Mid-year drug price hikes are back despite Inflation Reduction Act

STAT

At the start and halfway points of each year, many pharmaceutical companies raise drug prices to bolster revenue and reportedly fund new research. It’s almost a tradition. “It’s increasing prices on their existing portfolio. Continue to STAT+ to read the full story…

article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

In India, pharmaceutical companies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques. Indian pharmaceutical companies have specialised in reverse-engineering complex medicines and producing biosimilars as alternatives to costly biologics.

article thumbnail

PDA revises report on glass container manufacturing

European Pharmaceutical Review

Having been originally published in 2007, then revised in 2013, this latest 2023 edition addresses evolving standards and container types. According the PDA, the standardised quality criteria in TR 43 are intended as a guidance overview for container manufacturers and for incoming container acceptance inspection at pharmaceutical companies.

article thumbnail

Ensuring adequate sanitisation: disinfectant-resistant microbes in cleanrooms

European Pharmaceutical Review

More than 480 warning letters solely related to the failure to produce aseptic conditions because of deficient cleaning and disinfection systems for cleanrooms and their equipment, were issued by regulators between 2013 to 2018. Microbial resistance is one of the factors responsible for such failings.

article thumbnail

NHS patient data upload delayed by two months, says UK

pharmaphorum

The possibility of data being shared with third-parties including academic researchers and pharmaceutical companies – albeit pseudonymised – has raised concerns about whether the public is aware that they stand to lose control of private information on their physical, mental and sexual health.